Anti-interleukin-6 receptor antibody therapy-induced retinopathy in a patient with rheumatoid arthritis
{{output}}
Tocilizumab, a humanized anti-human interleukin-6 (IL-6) receptor monoclonal antibody, is beneficial for treating autoimmune conditions such as rheumatoid arthritis (RA). The most common adverse event is upper respiratory tract infection; ocular side effects a... ...
